Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Return on Sales: 2009-2020

Historic Return on Sales for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2020 value amounting to -0.28%.

  • Avadel Pharmaceuticals' Return on Sales rose 263.00% to 1.35% in Q4 2020 from the same period last year, while for Dec 2020 it was 1.35%, marking a year-over-year increase of 263.00%. This contributed to the annual value of -0.28% for FY2020, which is 100.00% up from last year.
  • As of FY2020, Avadel Pharmaceuticals' Return on Sales stood at -0.28%, which was up 77.96% from -1.28% recorded in FY2019.
  • In the past 5 years, Avadel Pharmaceuticals' Return on Sales ranged from a high of 0.39% in FY2017 and a low of -1.28% during FY2019.
  • Moreover, its 3-year median value for Return on Sales was -0.92% (2018), whereas its average is -0.83%.
  • In the last 5 years, Avadel Pharmaceuticals' Return on Sales slumped by 132bps in 2018 and then spiked by 100bps in 2020.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Return on Sales stood at -0.27% in 2016, then surged by 67bps to 0.39% in 2017, then tumbled by 132bps to -0.92% in 2018, then crashed by 36bps to -1.28% in 2019, then skyrocketed by 100bps to -0.28% in 2020.